"Are there investors and institutions that just short almost any stock with a pending R/S, as they do for biotechs approaching FDA decisions? If so, I'm guessing they would avoid VirTra anyway."
Jmodified,
You are correct. Any professionals, or investors/traders that know what they are doing won't touch VTSI short, unless the fundamentals fall apart.
News 
Market Data 
Discover 
